Dual-reporter phenotypic assay for human immunodeficiency viruses

about

Investigations of possible prodrug structures for 2-(2-mercaptophenyl)tetrahydropyrimidines: reductive conversion from anti-HIV agents with pyrimidobenzothiazine and isothiazolopyrimidine scaffolds.

P2860

Q41392869-B9ADCD5B-13C6-426F-A52D-E9D02A778084

P2860

Dual-reporter phenotypic assay for human immunodeficiency viruses

Item

http://www.wikidata.org/entity/Q36452419

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年学术文章

@wuu

2007年学术文章

@zh-cn

2007年学术文章

@zh-hans

2007年学术文章

@zh-my

2007年学术文章

@zh-sg

2007年學術文章

@yue

2007年學術文章

@zh

2007年學術文章

@zh-hant

name

Dual-reporter phenotypic assay for human immunodeficiency viruses

@ast

Dual-reporter phenotypic assay for human immunodeficiency viruses

@en

type

Item

label

Dual-reporter phenotypic assay for human immunodeficiency viruses

@ast

Dual-reporter phenotypic assay for human immunodeficiency viruses

@en

prefLabel

Dual-reporter phenotypic assay for human immunodeficiency viruses

@ast

Dual-reporter phenotypic assay for human immunodeficiency viruses

@en

P1476

Dual-reporter phenotypic assay for human immunodeficiency viruses

@en

P2093

Keiko Kajiwara

http://www.w3.org/2001/XMLSchema#string

Takeshi Naito

http://www.w3.org/2001/XMLSchema#string

Yasuko Sakagami

http://www.w3.org/2001/XMLSchema#string

P2860

Enfuvirtide, an HIV-1 fusion inhibitor, for drug-resistant HIV infection in North and South America

A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity

Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated beta-galactosidase gene

A recombinant retroviral system for rapid in vivo analysis of human immunodeficiency virus type 1 susceptibility to reverse transcriptase inhibitors.

Inactivation of the HIV LTR by DNA CpG methylation: evidence for a role in latency.

Principles of HIV resistance testing and overview of assay performance characteristics.

Rapid and simple phenotypic assay for drug susceptibility of human immunodeficiency virus type 1 using CCR5-expressing HeLa/CD4(+) cell clone 1-10 (MAGIC-5)

Clinical use of genotypic and phenotypic drug resistance testing to monitor antiretroviral chemotherapy.

Sensitivity of HIV-1 to entry inhibitors correlates with envelope/coreceptor affinity, receptor density, and fusion kinetics

Impact of genotypic resistance testing on physician selection of antiretroviral therapy.

P304

792-795

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JCM.01470-07

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Masao Matsuoka

Eiichi Kodama

P577

2007-12-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18094135

http://www.w3.org/2001/XMLSchema#string

P932

2238070

http://www.w3.org/2001/XMLSchema#string

Dual-reporter phenotypic assay for human immunodeficiency viruses

about

P2860

P2860

Dual-reporter phenotypic assay for human immunodeficiency viruses

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932